SCHEMBL19080883

SCHEMBL19080883

CC1(C)c2ccccc2-c2c1cc1c(oc3ccc4ccccc4c31)c2-c1cccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 6/20 0.33
AHR P35869 4/20 0.33
CYP1A1 P04798 2/20 0.33
PAX8 Q06710 2/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
CYP1B1 Q16678 1/20 0.32
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
SLC6A2 P23975 1/20 0.31
CHRNB4 P30926 1/20 0.31
SLC6A4 P31645 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CHRND Q07001 1/20 0.31
MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080918 0.95 ABCG2 (0.36) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19080852 0.93 AHR (0.33) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19080780 0.91 ABCG2 (0.35) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19080888 0.89 ABCG2 (0.34) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19080750 0.88 ABCG2 (0.33) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19080886 0.88 ABCG2 (0.33) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19080711 0.88 ABCG2 (0.36) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19080969 0.87 ABCG2 (0.34) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19081035 0.87 ABCG2 (0.33) ABCG2AHRCYP1A1PAX8CYP1A2
SCHEMBL19080743 0.86 ABCG2 (0.32) ABCG2AHRCYP1A1PAX8CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.